Treatment No. of lymphocytes (x10^5)/ ml ± SEM Fold change, with respect to
    Control TG TG-F
Control 4.15 ± 0.56      
TG24 6.35 ± 0.76 (+) 1.53    
TG24F 3.63 ± 0.60   (-) 1.75*  
TG24MF 3.86 ± 0.33   (-) 1.65* (+) 1.06
TG48 6.40 ± 0.12 (+) 1.54#    
TG48F 4.94 ± 0.06   (-) 1.30*  
TG48MF 3.77 ± 0.28   (-) 1.70* (-) 1.31*
TG72 6.52 ± 1.09 (+) 1.57    
TG72F 5.54 ± 0.23   (-) 1.18  
TG72MF 5.51 ± 0.58   (-) 1.18 (-) 1.01
TG96 6.64 ± 0.44 (+) 1.60#    
TG96F 3.21 ± 0.53   (-) 2.07*  
TG96MF 5.09 ± 0.33   (-) 1.30* (+) 1.59*
(#: p<0.05 versus Control; *: p<0.05 versus TG; *: p<0.05 versus TG-F)
Table 4: Differential count of lymphocytes in peripheral blood, seen after HE staining, under light microscope. Lymphocyte count decreased with fisetin, after 24 h (1.75 fold; p<0.05), 48 h (1.30 fold; p<0.05), 72 h and 96 h (2.07 fold; p<0.05), and with MCN+fisetin, after 48 h (1.31 fold; p<0.05) and 72 h (1.01 fold).